Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Forecast 2024-2033: Anticipated Size and Growth Trends
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market from 2024 to 2033?
The exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market has grown strongly in recent years. It is anticipated to rise from $5.24 billion in 2023 to $5.69 billion in 2024, at a CAGR of 8.7%. This growth is due to the higher prevalence of underlying conditions, advancements in diagnostic tools, pharmaceutical developments, and increased global healthcare access.
The exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market is expected to grow significantly, reaching $7.67 billion by 2028 at a CAGR of 7.7%. Factors contributing to this growth include telemedicine, patient education, regulatory changes, and data analytics. Trends include personalized treatment approaches, the development of novel therapies, minimally invasive diagnostics, and collaborative care models.
Claim Your Free Sample of the Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12992&type=smp
The growing number of diabetes patients is expected to fuel the expansion of the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to insufficient insulin production or ineffective use of insulin. EPI therapy, including pancreatic enzyme replacement therapy (PERT), improves nutrient absorption and glycemic control for those with diabetes. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, with projections to reach 643 million by 2030 and 783 million by 2045. This increase in diabetes cases is driving the market.
1) By Therapies: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Lifestyle Modifications Approach
2) By Diagnostics: Blood Tests, Magnetic Resonance Imaging (MRI), Endoscopic Ultra-Sonography (EUS), Computerized Tomography (CT) Scanning
3) By Drug Type: Generic, Branded
4) By Distribution Channel: Direct Tender, Retail Pharmacy , Third-Party Distributor, Other Distribution Channels
5) By End User: Hospitals, Specialty Clinics, Homecare, Diagnostic Center, Research And Academic Institutes, Other End Users
Companies in the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market are launching innovative studies to sustain their market position. In June 2021, Aimmune Therapeutics, a US-based biopharmaceutical company, launched the PACT-CP registry study to better understand the unmet needs of patients with EPI due to chronic pancreatitis. This study, involving 400 patients across 20 US facilities, aims to explore the therapeutic burden on these patients.
Order Now for Fast Delivery of Your Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Report!
Europe was the largest region in the wayside control market in 2023. The regions covered in the wayside control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Include
1. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Executive Summary
2. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Segments
3. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Size And Template Market Growth Rate
4. Key Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Trends
5. Major Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Drivers
……
25. Key Mergers And Acquisitions In The Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market
26. Top Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Companies
27. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Opportunities And Strategies
28. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Inflammatory Bowel Disease Treatment Global Market Report 2024
Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024
Gastric Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
